CRESUD INC. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by CRESUD INC. (Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria) covers the month of September 2026. The report serves as an English translation of a payment notice regarding the Company's Series L fixed-rate Notes.
Key Financial Metrics
The filing details a specific debt service event rather than comprehensive financial statements. Key metrics related to the Series L Notes include:
- Outstanding Principal: USD 70,381,079
- Annual Nominal Interest Rate: 7.25%
- Interest Payment Amount: USD 3,830,466.12
- Payment Currency: USD
- Payment Agent: Caja de Valores S.A.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or overall liquidity beyond this specific debt obligation.
Material Changes
The filing announces the commencement of the first interest installment for the Series L Notes issued on December 10, 2025. The payment covers the period from December 10, 2025, to September 10, 2026. No other material changes to operations or financial position are disclosed in this document.
Outlook, Risks, and Unusual Items
Management Commentary: The Company confirms the scheduled payment of the first interest installment on September 10, 2026. Eligible noteholders are those registered as of September 9, 2026.
Risks and Contingencies: The filing does not explicitly discuss risks, contingencies, or unusual items. It is a routine notification of a scheduled debt service payment.
Investor Verification Checklist
- Verify the registration date of September 9, 2026, to confirm eligibility for the interest payment.
- Confirm the receipt of the USD 3,830,466.12 interest payment via the designated Payment Agent, Caja de Valores S.A.
- Review the full terms of the Series L Notes issued on December 10, 2025, to understand future payment schedules and maturity conditions (due 2029).
- Monitor subsequent filings for broader financial performance data, as this 6-K is limited to the debt payment notice.